A comprehensive view of ESMO Congress. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

BioNTech presents positive Phase 1/2 data update for CAR-T cell therapy candidate BNT211 in advanced solid tumors at ESMO Congress 2023; the therapy combines BioNTech's CAR-T and FixVac platform technologies
Published: October 23, 2023 by BioNTech SE
GSK to highlight new data in NSCLC and endometrial cancer at ESMO Congress 2023, reinforcing potential of Jemperli as a backbone immuno-oncology therapy
Published: October 19, 2023 by PharmaBiz (India)

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count